Windgap Medical - About the company
Windgap Medical is a series B company based in Boston (United States), founded in 2011. It operates as a Provider of drug delivery autoinjector for the treatment of anaphylaxis. Windgap Medical has raised $76.7M in funding from SKK and Taiwania Capital. The company has 32 active competitors, including 7 funded and 3 that have exited. Its top competitors include companies like Crossject, Xeris Pharmaceuticals and Eveon.
Company Details
Provider of drug delivery autoinjector for the treatment of anaphylaxis. The company offers a device ANDIPEN that is a temperature-insensitive, and heat-stable alternative to the EpiPen, which is an auto-injector for severe allergies. The device uses a patent-pending microfluidics technology that injects Epinephrine to treat allergies
- Website
- www.windgapmedical.com/
- Registered Address
- Watertown,Massachusetts
Key Metrics
Founded Year
2011
Location
Boston, United States
Stage
Series B
Total Funding
$76.7M in 11 rounds
Latest Funding Round
Ranked
3rd among 32 active competitors
Employee Count
21 as on Jun 30, 2026
Legal entities associated with Windgap Medical
Windgap Medical is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
WINDGAP MEDICAL CIN: 453914066 , Belgium, Active | Dec 31, 1999 | - | 9 (As on Dec 31, 2022) | - |
Sign up to download Windgap Medical's company profile
Windgap Medical's funding and investors
Windgap Medical has raised a total funding of $76.7M over 11 rounds. Its first funding round was on 2012. Windgap Medical has 13 institutional investors.
Here is the list of recent funding rounds of Windgap Medical:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 06, 2023 | 4414205 | Series B | 7441469 | 1921212 | 2746823 | 3351573 |
Sep 07, 2021 | 4554003 | Series B | 4610401 | 6945210 | 4944305 | |
Feb 28, 2020 | 6667141 | Series B | 9640073 | 6296796 | 4314601 | 5640637 |
View details of Windgap Medical's funding rounds and investors
Windgap Medical's founders and board of directors
Founder? Claim ProfileWindgap Medical's employee count trend
Windgap Medical has 21 employees as of Jun 26. Here is Windgap Medical's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Windgap Medical's Competitors and alternates
Top competitors of Windgap Medical include Crossject, Xeris Pharmaceuticals and Eveon. Here is the list of Top 10 competitors of Windgap Medical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Needle-free self-injectable drugs | $40.3M | 60/100 | ||
2nd | Xeris Pharmaceuticals 2005, Chicago (United States), Public | Developer of liquid-stable injectables for the delivery of drugs | $155M | 60/100 | |
3rd | Windgap Medical 2011, Boston (United States), Series B | Provider of drug delivery autoinjector for the treatment of anaphylaxis | $76.7M | 44/100 | |
4th | Manufacture of connected medical devices focused on the preparation and administration of therapeutic treatment | $4.05M | 42/100 | ||
5th | Provider of needleless injectors for various medical applications | - | - | 36/100 | |
6th | Qlibrium 2014, Woburn (United States), Funding Raised | Provider of on‑body drug delivery systems | - | 36/100 | |
7th | Cellular Vehicles 2021, San Mateo (United States), Funding Raised | Developer of process automation tools for cell-based therapy manufacturing | - | 34/100 | |
8th | Asan Therapeutics Boston (United States), Unfunded | Developer of drug delivery technology to treat cancer patients | - | - | 32/100 |
9th | Pirouette Pharma 2021, Portsmouth (United States), Seed | Developer of auto-injector technology for injectable medicines and partner programs | $3.43M | 31/100 | |
10th | ![]() zephyrusinnovations.com 2022, Vancouver (Canada), Seed | Manufacturer of safety syringes and closed system transfer devices | $333K | - | 26/100 |
Looking for more details on Windgap Medical's competitors? Click here to see the top ones
Windgap Medical's Investments and acquisitions
Windgap Medical has made no investments or acquisitions yet.
Reports related to Windgap Medical
Here is the latest report on Windgap Medical's geography:
News related to Windgap Medical
•
Windgap Medical Closes Over $39M Series B-1 FundingFinSMEs•Jan 21, 2022•Windgap Medical, Taiwania Capital, SKK, Molex and 1 other
•
Windgap Medical Closes $17M Series B-1 Equity Financingcitybiz.co•Sep 07, 2021•Windgap Medical, Taiwania Capital, SKK, Molex and 1 other
•
•
•
Windgap Medical Announces Strategic Investment From Molex VenturesBarchart•Jan 24, 2019•Windgap Medical, SKK, Molex
•
Windgap Medical raises $12m for epinephrine auto-injectorDrug Delivery Business•Jan 17, 2019•Windgap Medical, SKK, Molex
•
Windgap Medical raises $3m for epinephrine auto-injectorArawali phosphate•Apr 08, 2016•Windgap Medical
•
Windgap Medical Awarded Nearly $1M Loan from MLSCNorth Shore InnoVentures•Dec 17, 2014•Windgap Medical
Are you a Founder ?
FAQs about Windgap Medical
Explore our recently published companies
- iBrandLabs - Hyderabad based, 2013 founded, Public company
- SmartIrrigate - Des Moines based, 2024 founded, Unfunded company
- Chrio - Hyderabad based, 2017 founded, Acquired company
- PreciAgro - Harare based, 2023 founded, Unfunded company
- Publishsutra - Hyderabad based, 2017 founded, Acquired company
- VerdiGen.ai - Dubai based, 2001 founded, Unfunded company
